ARCHIVES

Techniclone Wins Patent For Tumor Necrosis Therapy.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

Texts Of Workshop Report Summarized

November 8, 1996

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Working Group Considering formal Cap On size of Cancer Center Support Grants

March 22, 1996

President’s Cancer Panel Seeks Ways to Open Grants For More New Ideas

December 19, 1980

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983